Diagnostic and neuropathogenesis issues in human African trypanosomiasis

Area of Science:

• Neuroscience
• Immunology
• Parasitology

Background:

• Human African trypanosomiasis (HAT), or sleeping sickness, is a fatal parasitic disease caused by Trypanosoma parasites.
• Accurate staging into haemolymphatic and encephalitic stages is crucial due to different treatment strategies.
• Current diagnostics for central nervous system (CNS) involvement and melarsoprol treatment indications lack consensus.

Purpose of the Study:

• To address the urgent need for rapid, affordable, and reliable field diagnostics for HAT and CNS invasion.
• To investigate the role of pro-inflammatory and counter-inflammatory cytokines in meningoencephalitis severity.
• To utilize rodent models to understand post-treatment reactive encephalopathy and CNS parasite mechanisms.

Main Methods:

• Analysis of cerebrospinal fluid and plasma cytokine profiles in HAT patients.
• Utilizing rodent models to study post-treatment reactive encephalopathy.
• Investigating astrocyte activation and cytokine balance in CNS disease.
• Examining trypanosome infection mechanisms on CNS function and blood-brain barrier passage.

Main Results:

• Cytokine balance in cerebrospinal fluid and plasma is implicated in meningoencephalitis severity, particularly in Trypanosoma brucei rhodesiense infections.
• Rodent models successfully replicate human post-treatment reactive encephalopathy, highlighting astrocyte activation and cytokine roles.
• Animal models provide insights into direct trypanosome effects on CNS function, including circadian rhythm disruption.

Conclusions:

• Understanding cytokine dynamics is critical for managing HAT-induced meningoencephalitis.
• Rodent models are valuable tools for studying HAT pathogenesis and potential therapeutic targets.
• Further research is needed to develop improved diagnostics and treatments for HAT, especially for CNS-invasive disease.